PNC Financial Services Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$169K Buy
6,387
+2,530
+66% +$67K ﹤0.01% 2322
2025
Q1
$93.1K Buy
3,857
+1,078
+39% +$26K ﹤0.01% 2705
2024
Q4
$112K Sell
2,779
-3,460
-55% -$139K ﹤0.01% 2613
2024
Q3
$395K Buy
6,239
+1,396
+29% +$88.4K ﹤0.01% 1709
2024
Q2
$257K Buy
4,843
+1,260
+35% +$66.8K ﹤0.01% 1975
2024
Q1
$294K Buy
3,583
+2,578
+257% +$211K ﹤0.01% 1902
2023
Q4
$18.7K Buy
1,005
+5
+0.5% +$93 ﹤0.01% 3468
2023
Q3
$11.1K Sell
1,000
-669
-40% -$7.41K ﹤0.01% 3709
2023
Q2
$27.1K Buy
1,669
+669
+67% +$10.8K ﹤0.01% 3402
2023
Q1
$16.7K Hold
1,000
﹤0.01% 3579
2022
Q4
$9.4K Hold
1,000
﹤0.01% 3797
2022
Q3
$3K Sell
1,000
-1,978
-66% -$5.93K ﹤0.01% 4118
2022
Q2
$9K Buy
2,978
+1,978
+198% +$5.98K ﹤0.01% 3853
2022
Q1
$3K Hold
1,000
﹤0.01% 4132
2021
Q4
$5K Sell
1,000
-1,000
-50% -$5K ﹤0.01% 3990
2021
Q3
$13K Hold
2,000
﹤0.01% 3678
2021
Q2
$12K Buy
2,000
+500
+33% +$3K ﹤0.01% 3653
2021
Q1
$9K Buy
1,500
+500
+50% +$3K ﹤0.01% 3687
2020
Q4
$6K Sell
1,000
-4,500
-82% -$27K ﹤0.01% 3690
2020
Q3
$32K Buy
5,500
+4,500
+450% +$26.2K ﹤0.01% 2994
2020
Q2
$7K Hold
1,000
﹤0.01% 3571
2020
Q1
$5K Sell
1,000
-550
-35% -$2.75K ﹤0.01% 3612
2019
Q4
$12K Hold
1,550
﹤0.01% 3475
2019
Q3
$11K Hold
1,550
﹤0.01% 3535
2019
Q2
$13K Hold
1,550
﹤0.01% 3502
2019
Q1
$15K Buy
1,550
+1,250
+417% +$12.1K ﹤0.01% 3475
2018
Q4
$2K Hold
300
﹤0.01% 3879
2018
Q3
$5K Buy
+300
New +$5K ﹤0.01% 3830